|
CLRB Cellectar Biosciences Inc 1279704 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,653,946.00 |
| Balance Sheet |
|
Current Assets
|
$9,267,128.00 |
|
Assets
|
$11,119,761.00 |
|
Current Liabilities
|
$4,873,826.00 |
|
Liabilities
|
$6,402,651.00 |
|
Equity
|
$3,335,087.00 |
|
Shares Out
|
4240129.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,845,565.00 |
|
Investing Cash Flow
|
$-3,378.00 |
| Market Analysis |
Market Cap
|
$10,727,526.37 |
|
Price
|
$2.57 |
|
BVPS
|
0.79 |
|
PB
|
3.20 |
|
EPS
|
-1.33 |
|
FCF
|
$-4,848,943.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
| Apr |
May |
Jun |
| 2026-03-04 |
-8.35 |
|
|
2026-05-14 |
-1.33 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-3.39 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-1.41 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLRB documents filed with the SEC.
CLRB Filings
Clear
